Business
Starpharma pauses UK sales of COVID spray after regulator’s queries – Sydney Morning Herald
The Melbourne biotech has paused sales of its coronavirus fighting product after the UK medicines watchdog wrote to its distributor…
Australian biotech firm Starpharma has paused the sales of its coronavirus-fighting nasal spray in the United Kingdom after the British medicines regulator questioned promotional claims made about the product.
The ASX-listed firm applied the same active…
Continue Reading
-
Noosa News17 hours agoFull house as Minister shares vision for Sunshine Coast transport
-
General16 hours agoWill AI solve our productivity problem or increase unemployment?
-
General14 hours agoDash cam video shows spectacular Finke Desert Race crash
-
Business14 hours agoWhy I’d buy these top ASX 200 shares next